Science and Technology

What FODMAPs are and why they matterFODMAPs are short-chain carbohydrates that can be poorly absorbed in the small intestine and then fermented by bacteria in the colon. The acronym stands for fermentable oligosaccharides, disaccharides, monosaccharides and polyols. When these molecules reach the colon, they attract water and are rapidly fermented, which can cause gas, bloating, abdominal pain and altered bowel habits in susceptible people.When a low FODMAP approach helpsIrritable bowel syndrome (IBS): The strongest evidence supports a low FODMAP diet for reducing IBS symptoms. Clinical trials and meta-analyses report symptom improvement in roughly about half to three quarters of patients…

Bio-manufacturing employs living cells, enzymes, and broader biological systems to generate materials, chemicals, foods, and medicines, and fermentation-driven processes stand at the heart of this discipline, with bacteria, yeast, and fungi transforming feedstocks into high‑value products. Previously focused mostly on pharmaceuticals and food components, these methods are increasingly being applied to fuels, materials, agriculture, and a wide range of consumer goods, and multiple influential trends are hastening this evolution.Climate Pressure and the Push for Low-Carbon ManufacturingA major force behind this shift is the worldwide imperative to cut greenhouse gas emissions and lessen resource consumption, as conventional petrochemical production relies heavily…

Bio-manufacturing employs living cells, enzymes, and broader biological systems to generate materials, chemicals, foods, and medicines, and fermentation-driven processes stand at the heart of this discipline, with bacteria, yeast, and fungi transforming feedstocks into high‑value products. Previously focused mostly on pharmaceuticals and food components, these methods are increasingly being applied to fuels, materials, agriculture, and a wide range of consumer goods, and multiple influential trends are hastening this evolution.Escalating Climate Demands and the Move Toward Low-Carbon ProductionA major force behind this shift is the worldwide imperative to cut greenhouse gas emissions and lessen resource consumption, as conventional petrochemical production relies…

Neural Processing Units, commonly called NPUs, are specialized processors designed to accelerate artificial intelligence and machine learning workloads. Unlike CPUs, which handle general-purpose tasks, or GPUs, which excel at parallel graphics and compute operations, NPUs focus on matrix math, inference, and on-device learning with extreme efficiency. Alongside NPUs, the broader category of AI chips includes dedicated accelerators integrated into system-on-a-chip designs or offered as discrete components in PCs and servers.Over the past five years, AI workloads have shifted from cloud-centric processing toward on-device intelligence. This shift is driven by latency requirements, privacy concerns, and the need for energy efficiency. As…

Neural Processing Units, commonly called NPUs, are specialized processors designed to accelerate artificial intelligence and machine learning workloads. Unlike CPUs, which handle general-purpose tasks, or GPUs, which excel at parallel graphics and compute operations, NPUs focus on matrix math, inference, and on-device learning with extreme efficiency. Alongside NPUs, the broader category of AI chips includes dedicated accelerators integrated into system-on-a-chip designs or offered as discrete components in PCs and servers.Over the past five years, AI workloads have shifted from cloud-centric processing toward on-device intelligence. This shift is driven by latency requirements, privacy concerns, and the need for energy efficiency. As…

Synthetic biology first gained prominence through its impact on pharmaceuticals, where engineered microbes produce insulin, vaccines, and complex biologic drugs. Over the past decade, the same core capabilities—precise genetic design, scalable fermentation, and data-driven optimization—have matured and become cost-effective enough to address challenges far beyond medicine. As a result, synthetic biology is now expanding rapidly into materials science, targeting sectors such as textiles, construction, packaging, and electronics.This expansion is driven by a convergence of technological readiness, market demand for sustainability, and limitations of traditional material manufacturing.Technologies Driving the Widespread GrowthMultiple technological breakthroughs have increasingly reduced the obstacles to using synthetic…

Artificial intelligence is rapidly moving from experimental deployments to mission-critical systems across regulated industries such as finance, healthcare, energy, telecommunications, insurance, and pharmaceuticals. As AI increasingly influences decisions with legal, ethical, and societal impact, governance is no longer optional. It is becoming a foundational requirement driven by regulation, risk management, and public accountability.The Growing Influence of AI Across Critical Operational SettingsRegulated industries adopt AI to improve efficiency, accuracy, and scalability. Examples include credit scoring models in banking, diagnostic algorithms in healthcare, fraud detection in insurance, algorithmic trading in capital markets, and predictive maintenance in utilities. These systems often operate at…

Personalized medicine aims to tailor prevention, diagnosis, and treatment to the unique biological, environmental, and lifestyle characteristics of each patient. Over the past decade, this approach has moved from concept to practice, reshaping how therapies are developed and how clinical trials are designed. Advances in genomics, data science, and digital health are accelerating this transformation, while regulatory agencies and healthcare systems adapt to support more precise and patient-centered research models.Genomics and Multi-Omics as Foundational DriversThe steep drop in genome sequencing costs, paired with the expanding use of multi-omics approaches, has significantly transformed personalized medicine.Genomics: Through whole-genome and exome sequencing, researchers…

Zero-knowledge proofs, or ZKPs, originated in academic cryptography and gained mainstream visibility through blockchain and privacy-focused cryptocurrencies. Their core promise is simple yet powerful: one party can prove a statement is true without revealing the underlying data. As enterprises face mounting pressure to protect sensitive information, comply with strict regulations, and still collaborate across organizational boundaries, this capability is proving valuable far beyond digital assets.A hands-on perspective on zero-knowledge proofsAt an enterprise scale, ZKPs support credible trust while revealing almost nothing. Rather than sharing raw information, organizations can offer proofs that specific requirements have been satisfied. For example, a company…

Digital biomarkers are objective, quantifiable physiological and behavioral data collected through digital devices such as smartphones, wearable sensors, and connected medical tools. Unlike traditional biomarkers, which often rely on laboratory tests or in-clinic measurements, digital biomarkers are generated continuously in real-world settings. They capture signals like heart rhythm, physical activity, sleep patterns, voice characteristics, typing behavior, and movement dynamics, transforming everyday interactions with technology into health insights.From Episodic Care to Continuous MonitoringConventional health checkups usually occur sporadically through infrequent clinic appointments and brief diagnostic evaluations, while digital biomarkers move this approach toward ongoing monitoring. Around-the-clock tracking from wearable devices can…